An Integrated 3D bioprinted disease in a dish lung cancer model to simultaneously study drug efficacy, toxicity and metabolism
N. NP, M. Rotella, S. Vangala, U. Saxena
The paper develops a 3D bioprinted lung cancer model using human cells to simultaneously assess drug efficacy, toxicity, and metabolism.
bioRxiv · May 2, 2022 · PreprintPharmacology & Toxicology